West Paces Advisors’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-13
Closed -$4.48K – 442
2020
Q1
$4.48K Hold
13
– – ﹤0.01% 372
2019
Q4
$3.55K Hold
13
– – ﹤0.01% 426
2019
Q3
$3.47K Hold
13
– – ﹤0.01% 411
2019
Q2
$3.25K Hold
13
– – ﹤0.01% 413
2019
Q1
$1.37K Hold
13
– – ﹤0.01% 455
2018
Q4
$1.11K Hold
13
– – ﹤0.01% 463
2018
Q3
$1.57K Hold
13
– – ﹤0.01% 456
2018
Q2
$357 Hold
13
– – ﹤0.01% 481
2018
Q1
$547 Hold
13
– – ﹤0.01% 444
2017
Q4
$733 Hold
13
– – ﹤0.01% 464
2017
Q3
$644 Hold
13
– – ﹤0.01% 464
2017
Q2
$865 Hold
13
– – ﹤0.01% 486
2017
Q1
$830 Hold
13
– – ﹤0.01% 487
2016
Q4
$652 Buy
+13
New +$2K ﹤0.01% 534

Other funds holding CVM

West Paces Advisors's CVM Position: Q2 2020 in Review

West Paces Advisors sold out of CEL-SCI Corp (CVM) in Q2 2020, closing a stake of 13 shares — an estimated $4.48K sold.

West Paces Advisors first reported a position in CVM in Q4 2016 and held it in 14 quarters. The position peaked at $4.48K in Q1 2020. 96 funds tracked by Wall St. Rank hold CVM as of Q2 2020.

  • West Paces Advisors reported no remaining CEL-SCI Corp position as of Q2 2020 after selling out during the quarter.
  • West Paces Advisors sold 13 CEL-SCI Corp shares in Q2 2020, an estimated $4.48K.
  • West Paces Advisors first reported a position in CEL-SCI Corp in Q4 2016 and held it in 14 quarters.
  • West Paces Advisors's CEL-SCI Corp position peaked at $4.48K in Q1 2020.
  • 96 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2020.

Based on West Paces Advisors's 13F filing for Q2 2020, filed 20 Dec 2023.